Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/MI/Kalamazoo
Updated September 2026 from ClinicalTrials.gov

Paid Clinical Trials in Kalamazoo, MI

Studies commonly pay $75 to $4,500 per completed study

103 clinical trials are currently recruiting participants within 30 miles of Kalamazoo. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

103studies recruiting
7+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Kalamazoo right now

Top 25 of 103 recruiting studies, sorted by proximity — each links to its official registry page

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT04510597)

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial

Acute Ischemic Stroke Phase 3 Interventional 404 participants sought
Bronson Methodist Hospital/Western Michigan University Homer Stryker M.D. School of Medicine — Kalamazoo, Michigan (1.2 mi) · Sponsor: Mercy Health Ohio
See eligibility & contact on ClinicalTrials.gov (NCT05611242)

A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma

High Grade Osteosarcoma, Localized Osteosarcoma Phase 2, Phase 3 Interventional 1,122 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05691478)

ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack

Cardiovascular Risk, Acute Myocardial Infarction (AMI) Phase 3 Interventional 10,000 participants sought
WMU Homer Stryker MD School of Medicine — Kalamazoo, Michigan (1.2 mi) · Sponsor: Novo Nordisk A/S
See eligibility & contact on ClinicalTrials.gov (NCT06118281)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06418204)

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 Phase 3 Interventional 3,680 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06058377)

Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer

Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma Phase 3 Interventional 336 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT07061977)

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT01810913)

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma N/A Observational 800 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: University of Rochester
See eligibility & contact on ClinicalTrials.gov (NCT06073431)

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

Pancreatic Neoplasm N/A Observational 770 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT04239573)

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

Classic Follicular Lymphoma, Follicular Lymphoma With Unusual Cytological Features Phase 3 Interventional 600 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06337318)

Project: Every Child for Younger Patients With Cancer

Adrenal Gland Pheochromocytoma, Carcinoma In Situ N/A Observational 75,000 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02402244)

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma Phase 3 Interventional 62 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05235165)

Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors

Colorectal Cancer Stage II, Colorectal Cancer Stage III Phase 3 Interventional 1,057 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT07018869)

A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia

Schizophrenia Phase 1 Interventional 64 participants sought
Western Michigan University — Kalamazoo, Michigan (1.2 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT07615426)

Adaptive Decision-making And Personalized Treatment for PTSD (ADAPT-PTSD)

Posttraumatic Stress Disorder, PTSD N/A Interventional 302 participants sought
Battle Creek VA — Battle Creek, Michigan (21.2 mi) · Sponsor: The University of Texas Health Science Center at San Antonio
See eligibility & contact on ClinicalTrials.gov (NCT07176273)

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

Ovarian Neoplasms, Fallopian Tube Neoplasms Phase 3 Interventional 1,630 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07213804)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 Phase 3 Interventional 306 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06498635)

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

Acute Treatment of Migraine Phase 3 Interventional 600 participants sought
Wellnow Urgent Care and Research — Kalamazoo, Michigan (1.2 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT04743141)

Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery

C.Surgical Procedure; Disruption of Wound, Suture N/A Interventional 100 participants sought
West Michigan Cancer Center — Kalamazoo, Michigan (1.2 mi) · Sponsor: West Michigan Cancer Center
See eligibility & contact on ClinicalTrials.gov (NCT06063577)

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia Phase 2 Interventional 461 participants sought
Bronson Methodist Hospital — Kalamazoo, Michigan (1.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04546399)
Actively enrolling

Studies you may be able to join near Kalamazoo

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Kalamazoo

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Center for Clinical Research at WMed

★ 5.0 (1 reviews)
1000 Oakland Dr, Kalamazoo, MI 49008
(269) 337-4264
"I would like overnight clinic study paid. Kalamazoo"
— Terri Dee Little, 5★

Center For Clinical Research Solutions

★ 5.0
321 S Kalamazoo Mall #214, Kalamazoo, MI 49007
(269) 488-5947

West Michigan Cancer Center

★ 4.9 (1299 reviews)
200 N Park St, Kalamazoo, MI 49007
(269) 382-2500
"Individuals that work here are informative and care about their patients."
— Kenneth Randt, 5★

West Michigan Clinical Research Center

2093 Health Dr SW Ste 201, Wyoming, MI 49519
(616) 328-5344

WMed Innovation Center

★ 5.0
4717 Campus Dr, Kalamazoo, MI 49008
(269) 353-1823

Lighthouse Autism Center - Kalamazoo

★ 3.3 (8 reviews)
4625 W KL Ave, Kalamazoo, MI 49006
(269) 249-1490
"Lighthouse helped my child be comfortable with herself and offered her support and fun ways to tackle challenges. The staff are all wonderful and de…"
— Angel Raatz, 5★

Kalamazoo Autism Center

★ 4.5 (8 reviews)
4200 S Westnedge Ave, Kalamazoo, MI 49008
(269) 459-7821
"My son attended the autism center for 2 years. During that time I cannot recall one issue with the Kalamazoo Autism Center. This was the most seamles…"
— Kyria, 5★

Clinical trials in Kalamazoo: what's recruiting

The Kalamazoo area currently has 103 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Kalamazoo, the most active research areas are:

  • Cancer & Oncology15 studies
  • Liver & Kidney2 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health2 studies

Every listing shows the study phase, the recruiting site and its distance from Kalamazoo, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Kalamazoo

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Kalamazoo participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Kalamazoo pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Are clinical trials in Kalamazoo safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Kalamazoo, MI?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
What is the difference between a research center and a hospital study in Kalamazoo?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Kalamazoo typically complete one or two studies per year.

Paid clinical trials near Kalamazoo

Other metros within reach

Grand Rapids, MI461 Elkhart, IN105 South Bend, IN105 Lansing, MI175 Muskegon, MI58 Fort Wayne, IN118 Ann Arbor, MI1,171 South Lyon, MI1,319

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Kalamazoo Bladder Issues Due To Spinal Cord Injury in Kalamazoo All conditions

More of MI

South Lyon1,319 Detroit1,189 Ann Arbor1,171 Grand Rapids461 Lansing175 Flint172 Muskegon58

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts